Second Time Lucky? Sumatriptan One Of Three Switches On The Cards In Germany

A second attempt at switching sumatriptan for migraines, as well as switch applications for non-steroidal anti-inflammatories ketoprofen and liquid ibuprofen, are all on the agenda at Germany's next Expert Committee for Prescription meeting in June. 

Migraine
Germany's Expert Committee Will Look At Sumatriptan For Migraines • Source: Shutterstock

Germany’s Expert Committee for Prescription will consider three prescription-to-OTC switch applications at its next meeting on 27 June, including a second attempt at sumatriptan for migraines, as well as non-steroidal anti-inflammatories ketoprofen and liquid ibuprofen.

The first prescription-to-OTC switch on the table at the next committee meeting is migraine and cluster headache medicine sumatriptan (50mg...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Rx-to-OTC Switch

More from Health